Drug Detail:Toremifene (Toremifene [ tor-em-i-feen ])
Drug Class: Hormones / antineoplastics Selective estrogen receptor modulators
60 mg orally once daily
Duration of therapy: Treatment is generally continued until disease progression is observed.
Use: Treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.
No adjustment listed in the manufacturer product information; however, dosage adjustment is unlikely to be necessary.
No adjustment listed in the manufacturer product information; however, hepatic impairment increases the half-life of this drug. Caution is recommended.
US BOXED WARNING:
Data not available.
Administration Advice: